{"id":"sequential-therapy-10-days","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Abdominal pain"}]},"_chembl":{"chemblId":"CHEMBL39541","moleculeType":"Small molecule","molecularWeight":"785.11"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This approach is used to treat infections caused by resistant bacteria, where a combination of antibiotics is used to target the bacteria and prevent the development of resistance. The specific antibiotics used in sequential therapy may vary depending on the type of infection and the patient's medical history.","oneSentence":"Sequential therapy is a treatment approach that involves a combination of antibiotics to treat bacterial infections.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:07:28.973Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Community-acquired pneumonia"},{"name":"Acute bacterial exacerbation of chronic bronchitis"}]},"trialDetails":[{"nctId":"NCT06498648","phase":"PHASE1, PHASE2","title":"Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-03-18","conditions":"Advanced Dedifferentiated Liposarcoma, Advanced Leiomyosarcoma, Advanced Soft Tissue Sarcoma","enrollment":74},{"nctId":"NCT04267848","phase":"PHASE3","title":"Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2020-06-16","conditions":"Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma, Lung Non-Squamous Non-Small Cell Carcinoma","enrollment":1210},{"nctId":"NCT06980480","phase":"PHASE3","title":"A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma","status":"RECRUITING","sponsor":"Takeda","startDate":"2026-01-14","conditions":"Multiple Myeloma, Secondary Immunodeficiency","enrollment":183},{"nctId":"NCT04889716","phase":"PHASE2","title":"CAR-T Followed by Bispecific Antibodies","status":"RECRUITING","sponsor":"Abramson Cancer Center at Penn Medicine","startDate":"2021-11-05","conditions":"Large B-cell Lymphoma, DLBCL - Diffuse Large B Cell Lymphoma","enrollment":42},{"nctId":"NCT06562907","phase":"PHASE1","title":"Study of GS-4571 in Healthy Participants, Nondiabetic Obese Participants, and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM)","status":"RECRUITING","sponsor":"Gilead Sciences","startDate":"2024-08-28","conditions":"Weight Management","enrollment":134},{"nctId":"NCT04273945","phase":"PHASE3","title":"Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension","status":"ACTIVE_NOT_RECRUITING","sponsor":"Actelion","startDate":"2020-06-30","conditions":"Pulmonary Arterial Hypertension","enrollment":935},{"nctId":"NCT07443826","phase":"PHASE1, PHASE2","title":"CALM-AF-AI: Counteracting Age-related Loss of Muscle With AAV-Follistatin Combined With Angiogenesis-Inducing VEGF Plasmid Gene Therapy","status":"RECRUITING","sponsor":"Unlimited Biotechnology LLC","startDate":"2026-03-31","conditions":"Age-related Muscle Decline","enrollment":12},{"nctId":"NCT03223155","phase":"PHASE1","title":"Concurrent or Sequential Immunotherapy and Radiation Therapy in Patients With Metastatic Lung Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Chicago","startDate":"2017-09-07","conditions":"Stage IV Small Cell Lung Cancer","enrollment":78},{"nctId":"NCT04928807","phase":"PHASE3","title":"Short-Course Radiotherapy Followed by Neoadjuvant Chemotherapy and Camrelizumab in Locally Advanced Rectal Cancer (UNION)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2021-07-20","conditions":"Rectal Cancer","enrollment":231},{"nctId":"NCT07439497","phase":"PHASE2","title":"Definitive Hypofractionated Intensity-modulated Radiation Theraphy With Concurrent Chemotherapy in Cervical Cancer","status":"RECRUITING","sponsor":"Samsung Medical Center","startDate":"2025-12-09","conditions":"Cervical Cancer","enrollment":34},{"nctId":"NCT07433387","phase":"PHASE1, PHASE2","title":"Exploratory Study of LP-98 for Injection in ART-Naive HIV-Infected Individuals","status":"RECRUITING","sponsor":"Shanxi Kangbao Biological Product Co., Ltd.","startDate":"2026-01-29","conditions":"HIV","enrollment":30},{"nctId":"NCT07035119","phase":"PHASE1, PHASE2","title":"Transcranial Magnetic Stimulation for Chronic Scrotal Content Pain","status":"NOT_YET_RECRUITING","sponsor":"Medical University of South Carolina","startDate":"2026-03","conditions":"Scrotal Pain","enrollment":50},{"nctId":"NCT06325748","phase":"PHASE1","title":"SENTI-202: Off-the-shelf Logic Gated CAR NK Cell Therapy in Adults With CD33 and/or FLT3 Blood Cancers Including AML/MDS","status":"ACTIVE_NOT_RECRUITING","sponsor":"Senti Biosciences","startDate":"2024-04-22","conditions":"AML/MDS, CD33 Expressing Hematological Malignancies, FLT3 Expressing Hematological Malignancies","enrollment":21},{"nctId":"NCT06685809","phase":"PHASE1","title":"A Phase 1 Study of FZ008-145 in Healthy Subjects.","status":"RECRUITING","sponsor":"Guangzhou Fermion Technology Co., LTD","startDate":"2024-11-25","conditions":"Healthy","enrollment":190},{"nctId":"NCT05464121","phase":"NA","title":"A Blended Intervention for Adjustment Disorder.","status":"COMPLETED","sponsor":"Universitat Jaume I","startDate":"2022-11-18","conditions":"Adjustment Disorders","enrollment":41},{"nctId":"NCT07275905","phase":"PHASE1","title":"Bacteriophages for Adults With Cystic Fibrosis and Chronic Achromobacter Lung Infection","status":"NOT_YET_RECRUITING","sponsor":"Ghady Haidar","startDate":"2026-03","conditions":"Cystic Fibrosis (CF), Achromobacter Infection","enrollment":12},{"nctId":"NCT07224334","phase":"PHASE1","title":"Role of Alpha-to-beta Cell Communication to Adapt Insulin Secretion to Insulin Resistance.","status":"RECRUITING","sponsor":"David D'Alessio, M.D.","startDate":"2025-12-30","conditions":"Diabetes (DM)","enrollment":30},{"nctId":"NCT07381582","phase":"EARLY_PHASE1","title":"Safety, Tolerability and Preliminary Efficacy of 161Tb-LNC1011 (PSMA Radioligand) in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)","status":"NOT_YET_RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2026-01-01","conditions":"Prostate Cancer","enrollment":15},{"nctId":"NCT01217931","phase":"PHASE2","title":"Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy: The START Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2011-01-19","conditions":"Kidney Cancer","enrollment":180},{"nctId":"NCT07025226","phase":"EARLY_PHASE1","title":"Sequential Treatments or Combinations Including Dasatinib, Quercetin, Fisetin and/or Temozolomide for the Treatment of Previously Treated Glioma With Residual Disease","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-08-12","conditions":"Glioma","enrollment":10},{"nctId":"NCT06974786","phase":"PHASE2","title":"Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma","status":"RECRUITING","sponsor":"SCRI Development Innovations, LLC","startDate":"2025-08-08","conditions":"Multiple Myeloma, Newly Diagnosed, Multiple Myeloma (MM)","enrollment":100},{"nctId":"NCT03505905","phase":"PHASE1, PHASE2","title":"A Neurosteroid Intervention for Menopausal and Perimenopausal Depression","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2018-09-01","conditions":"Major Depressive Disorder, Menopause, Perimenopause","enrollment":73},{"nctId":"NCT07344194","phase":"PHASE1, PHASE2","title":"Dual-Site Transcranial Magnetic Stimulation of the Supplementary Motor Area and Cerebellum for the Treatment of Essential Tremor.","status":"RECRUITING","sponsor":"São Paulo State University","startDate":"2026-01-15","conditions":"Essential Tremor","enrollment":36},{"nctId":"NCT07349225","phase":"PHASE2","title":"Iparomlimab and Tuvonralimab Injection Combined With Chemotherapy and Sequential Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer","status":"NOT_YET_RECRUITING","sponsor":"The Second Affiliated Hospital of Dalian Medical University","startDate":"2026-01-31","conditions":"ES-SCLC","enrollment":46},{"nctId":"NCT06429449","phase":"PHASE1","title":"Mitoxantrone for Venetoclax Resistant Acute Myeloid Leukemia","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2024-07-21","conditions":"Leukemia, Myeloid Leukemia, Monocytic Leukemia","enrollment":30},{"nctId":"NCT07325734","phase":"NA","title":"The Effectiveness of Guided Written Exposure Therapy for Complex PTSD in Adolescents","status":"RECRUITING","sponsor":"Peking University","startDate":"2025-10-10","conditions":"CPTSD, Compelx Post-traumatic Stress Disorder","enrollment":120},{"nctId":"NCT06437626","phase":"PHASE3","title":"Efficacy and Safety of Mexidol® in Stroke Therapy","status":"COMPLETED","sponsor":"Pharmasoft","startDate":"2019-11-18","conditions":"Ischemic Stroke","enrollment":304},{"nctId":"NCT07146230","phase":"PHASE2","title":"The Selective Personalized Radio-Immunotherapy for Locally Advanced Non-Small Cell Lung Cancer Trial 2","status":"NOT_YET_RECRUITING","sponsor":"Montefiore Medical Center","startDate":"2026-03-01","conditions":"Non-small Cell Lung Cancer","enrollment":52},{"nctId":"NCT07264153","phase":"NA","title":"Laser Therapy in the Isotretinoin-Induced Sacroiliitis","status":"RECRUITING","sponsor":"Uşak University","startDate":"2025-11-24","conditions":"Sacroilitis","enrollment":50},{"nctId":"NCT04570943","phase":"PHASE2","title":"Sequential Treatment With GEMBRAX and Then FOLFIRINOX Followed by Stereotactic MRI-guided Radiotherapy in Patients With Locally Advanced Pancreatic Cancer","status":"RECRUITING","sponsor":"Institut du Cancer de Montpellier - Val d'Aurelle","startDate":"2021-06-16","conditions":"Locally Advanced Pancreatic Adenocarcinoma","enrollment":103},{"nctId":"NCT06409390","phase":"PHASE2","title":"Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer","status":"RECRUITING","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2024-08-14","conditions":"Metastatic Breast Cancer","enrollment":15},{"nctId":"NCT07150767","phase":"PHASE1","title":"A Clinical Study to Explore the Safety, Tolerability, and Efficacy of Recombinant Human nsIL12 Oncolytic Adenovirus Injection (BioTTT001) Combined With Neoadjuvant Treatment for Locally Advanced Breast Cancer","status":"WITHDRAWN","sponsor":"Beijing Bio-Targeting Therapeutics Technology Co., Ltd","startDate":"2025-03-26","conditions":"Locally Advanced Breast Cancer (LABC)","enrollment":""},{"nctId":"NCT02157883","phase":"PHASE1","title":"Study to Assess the Effect of Itraconazole (a CYP3A4 Inhibitor) on the Pharmacokinetics of AZD9291, in Patients With EGFR Positive Non-small Cell Lung Cancer. Patients Will be Chosen From Those Who Have Already Been Prescribed an EGFR TKI Medicine (Such as Iressa or Tarceva)","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2014-11-06","conditions":"Advanced Non Small Cell Lung Cancer, Advanced (Inoperable) Non Small Cell Lung Cancer","enrollment":39},{"nctId":"NCT04833907","phase":"PHASE1, PHASE2","title":"rAAV-Olig001-ASPA Gene Therapy for Treatment of Children With Typical Canavan Disease","status":"ENROLLING_BY_INVITATION","sponsor":"Myrtelle Inc.","startDate":"2021-04-01","conditions":"Canavan Disease","enrollment":24},{"nctId":"NCT06928662","phase":"PHASE1, PHASE2","title":"Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse","status":"RECRUITING","sponsor":"Fred Hutchinson Cancer Center","startDate":"2025-09-23","conditions":"Acute Myeloid Leukemia, Acute Undifferentiated Leukemia, Mixed Phenotype Acute Leukemia","enrollment":36},{"nctId":"NCT06442566","phase":"PHASE1, PHASE2","title":"ACTION: Trial of Adding Buprenorphine, CBT, and TMS to Improve Outcomes of Long-Term Opioid Therapy for Chronic Pain","status":"RECRUITING","sponsor":"Medical University of South Carolina","startDate":"2024-08-12","conditions":"Opioid Withdrawal, Chronic Pain","enrollment":240},{"nctId":"NCT06764108","phase":"NA","title":"Multimodality Adaptive Intervention for Post-Inpatient Hospitalization Suicide Risk Reduction","status":"NOT_YET_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2026-03","conditions":"Suicidal Ideation, Suicidal Behavior","enrollment":360},{"nctId":"NCT07217288","phase":"NA","title":"Complete Decongestive Therapy Versus Non-pneumatic Compression Therapy in Post Mastectomy Lymphedema","status":"NOT_YET_RECRUITING","sponsor":"Lahore University of Biological and Applied Sciences","startDate":"2025-10-26","conditions":"Lymphedema, Breast Cancer, Mastectomy Related Lymphedema, Post Mastectomy Lymphedema","enrollment":52},{"nctId":"NCT06814496","phase":"PHASE1, PHASE2","title":"Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors","status":"RECRUITING","sponsor":"University of Arizona","startDate":"2025-09-08","conditions":"Melanoma, Medullary Thyroid Cancer, Sinonasal Undifferentiated Carcinoma","enrollment":30},{"nctId":"NCT06834490","phase":"PHASE3","title":"Safety and Efficacy of Sequential Therapy With Mexidol® in Patients With Chronic Cerebral Ischemia","status":"COMPLETED","sponsor":"Pharmasoft","startDate":"2019-11-05","conditions":"Chronic Cerebral Ischemia","enrollment":318},{"nctId":"NCT05428488","phase":"PHASE3","title":"Efficacy of a Sequential Treatment Strategy in Rheumatoid Arthritis","status":"RECRUITING","sponsor":"University Hospital, Montpellier","startDate":"2022-11-28","conditions":"Rheumatoid Arthritis","enrollment":220},{"nctId":"NCT04257448","phase":"PHASE1, PHASE2","title":"Safety and Tolerance of Epigenetic and Immunomodulating Drugs Combined With Chemotherapeutics in Patients Suffering From Advanced Pancreatic Cancer","status":"COMPLETED","sponsor":"GWT-TUD GmbH","startDate":"2020-05-25","conditions":"Pancreas Cancer, Pancreatic Adenocarcinoma, Pancreatic Ductal Adenocarcinoma","enrollment":75},{"nctId":"NCT06931093","phase":"NA","title":"The Effectiveness of Group Guided Written Exposure Therapy for CPTSD Symptoms Among Adolescents","status":"RECRUITING","sponsor":"Peking University","startDate":"2025-04-10","conditions":"CPTSD, Compelx Post-traumatic Stress Disorder","enrollment":120},{"nctId":"NCT07185893","phase":"NA","title":"A Multicenter, Open-label, Randomized Controlled Trial Evaluating the Efficacy and Safety of Romiplostim N01 in the Treatment of Thrombocytopenia Associated With Concurrent/Sequential Chemoradiotherapy and Chemotherapy Combined With/Without Immunotherapy in Solid Tumors","status":"NOT_YET_RECRUITING","sponsor":"Jun wang","startDate":"2025-09","conditions":"Solid Tumor Malignancies, Cancer, CTIT-Chemotherapy Induced Thrombocytopenia, Thrombocytopenia","enrollment":106},{"nctId":"NCT01559935","phase":"PHASE2","title":"Carfilzomib, Clarithromycin (Biaxin®), Lenalidomide (Revlimid®), and Dexamethasone (Decadron®) [Car-BiRD] Therapy for Subjects With Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2012-04-19","conditions":"Multiple Myeloma","enrollment":74},{"nctId":"NCT07152340","phase":"PHASE4","title":"The Safety and Efficacy of Sequential Hormone Therapy and IBI311 Therapy in Patients With Active Moderate to Severe TAO in the Initial Treatment.","status":"RECRUITING","sponsor":"Shanghai Changzheng Hospital","startDate":"2025-04-10","conditions":"Thyroid Associated Ophthalmopathies","enrollment":64},{"nctId":"NCT07152366","phase":"PHASE4","title":"Efficacy and Safety of Sequential Hormone Therapy and Tetuzumab Therapy in Patients With Moderate to Severe TAO in the Active Stage After Glucocorticoid Treatment.","status":"RECRUITING","sponsor":"Shanghai Changzheng Hospital","startDate":"2025-04-15","conditions":"Thyroid Associated Ophthalmopathies","enrollment":96},{"nctId":"NCT04332848","phase":"PHASE4","title":"Susceptibility Testing Guided Versus Empirical Therapy for Refractory H. Pylori Infection","status":"RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2020-07-28","conditions":"Helicobacter Pylori Infection","enrollment":360},{"nctId":"NCT07130253","phase":"NA","title":"Efficacy of Vonoprazan-based Rescue Therapy for H. Pylori Eradication","status":"NOT_YET_RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2025-08-18","conditions":"HELICOBACTER PYLORI INFECTIONS","enrollment":220},{"nctId":"NCT05935787","phase":"PHASE3","title":"Cytoflavin in the Complex Rehabilitation of Stroke Patients","status":"COMPLETED","sponsor":"POLYSAN Scientific & Technological Pharmaceutical Company","startDate":"2023-06-09","conditions":"Stroke","enrollment":240},{"nctId":"NCT04013802","phase":"PHASE1","title":"TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.","status":"RECRUITING","sponsor":"Baylor College of Medicine","startDate":"2021-03-08","conditions":"Viral Infection","enrollment":47},{"nctId":"NCT02650648","phase":"PHASE1","title":"Humanized Anti-GD2 Antibody Hu3F8 and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2016-01-05","conditions":"Neuroblastoma, High-Risk","enrollment":85},{"nctId":"NCT07091305","phase":"PHASE2","title":"A Study of QL1706 Combined With Chemotherapy Induction on Sequential Immunotherapy Consolidation in Patients With Limited-Stage Small Cell Lung Cancer After Chemoradiotherapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Shanghai Chest Hospital","startDate":"2025-07-01","conditions":"Limited-stage Small Cell Lung Cancer (LS-SCLC), Chemoradiotherapy, Induction Therapy","enrollment":28},{"nctId":"NCT07088523","phase":"PHASE4","title":"Traditional Chinese Medicine Intervention for Ischemic Cardiovascular Disease Comorbid With Diabetes Mellitus: An Efficacy Comparative Study","status":"NOT_YET_RECRUITING","sponsor":"Guangzhou University of Traditional Chinese Medicine","startDate":"2025-07-31","conditions":"Diabete Mellitus, Ischemic Cardiovascular Disease","enrollment":4205},{"nctId":"NCT07067255","phase":"PHASE1, PHASE2","title":"Sequential CD146 and GPC3 CAR-T Cell Therapy in Advanced Ovarian Cancer","status":"RECRUITING","sponsor":"Essen Biotech","startDate":"2025-04-29","conditions":"Ovarian Cancer, Ovarian Carcinoma, Ovarian Sarcoma","enrollment":80},{"nctId":"NCT07066982","phase":"PHASE1, PHASE2","title":"Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas","status":"RECRUITING","sponsor":"Essen Biotech","startDate":"2025-05-29","conditions":"Sarcoma, Sarcoma, Kaposi, Sarcoma, Ewing","enrollment":60},{"nctId":"NCT07064278","phase":"NA","title":"Combined Diagnostic Approach for Refractory Mycoplasma Pneumonia in Children","status":"COMPLETED","sponsor":"Children's Hospital of Hebei Province","startDate":"2022-12-01","conditions":"Refractory Mycoplasma Pneumoniae Pneumonia","enrollment":260},{"nctId":"NCT06379087","phase":"PHASE2","title":"Radiation Therapy Followed by Tislelizumab and Anlotinib Aeoadjuvant/Adjuvant Therapy for Stage II-IIIA NSCLC","status":"RECRUITING","sponsor":"Ji Yongling","startDate":"2024-05-01","conditions":"Non-Small Cell Lung Cancer","enrollment":20},{"nctId":"NCT06520345","phase":"PHASE3","title":"The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)","status":"RECRUITING","sponsor":"Telix Pharmaceuticals (Innovations) Pty Limited","startDate":"2024-07-26","conditions":"Metastatic Castration-resistant Prostate Cancer","enrollment":430},{"nctId":"NCT07057427","phase":"PHASE3","title":"Efficacy of Nab-PHP Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast Cancer","status":"RECRUITING","sponsor":"Henan Cancer Hospital","startDate":"2025-06-24","conditions":"Breast Cancer","enrollment":812},{"nctId":"NCT06491550","phase":"PHASE1","title":"A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4144 as Well as the Impact of AZD4144 on the Pharmacokinetics of Rosuvastatin and Furosemide in Healthy Participants","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2024-07-15","conditions":"Healthy Participants","enrollment":91},{"nctId":"NCT03693677","phase":"PHASE2","title":"First Line Metastatic Pancreatic Cancer : 5FU/LV+Nal-IRI, Gemcitabine+Nab-paclitaxel or a Sequential Regimen of 2 Months 5FU/LV+Nal-IRI","status":"COMPLETED","sponsor":"Federation Francophone de Cancerologie Digestive","startDate":"2018-11-16","conditions":"Metastatic Pancreatic Cancer","enrollment":288},{"nctId":"NCT06439693","phase":"PHASE2","title":"The SAPPHO Study: Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer","status":"RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2024-08-08","conditions":"Breast Cancer Female, Breast Cancer, Breast Cancer Metastatic","enrollment":72},{"nctId":"NCT06665178","phase":"PHASE2","title":"Genomic and Transcriptomic Predictors of Sequential SG Sensitivity After T-DXd in ER+/HER2-Low Metastatic Breast Cancer","status":"RECRUITING","sponsor":"British Columbia Cancer Agency","startDate":"2025-03-31","conditions":"Breast Cancer","enrollment":20},{"nctId":"NCT03496506","phase":"PHASE1","title":"A Clinical Study to Assess the Effect of Clopidogrel on the Pharmacokinetics of Selexipag and Its Active Metabolite in Healthy Male Subjects","status":"COMPLETED","sponsor":"Actelion","startDate":"2018-03-05","conditions":"Healthy Subjects","enrollment":22},{"nctId":"NCT07032129","phase":"PHASE1, PHASE2","title":"Sequential CAR-T Cells Targeting BCMA/GPRC5D in Patients With Relapsed/ Refractory Multiple Myeloma","status":"RECRUITING","sponsor":"Essen Biotech","startDate":"2025-04-29","conditions":"Multiple Myeloma, Multiple Myeloma in Relapse, Multiple Myeloma Progression","enrollment":60},{"nctId":"NCT07028151","phase":"NA","title":"Comparison of the Effects of Classical Massage and Conventional Treatment Methods in Phone Addicted Bruxist Patients","status":"ENROLLING_BY_INVITATION","sponsor":"Bartın Unıversity","startDate":"2024-04-01","conditions":"Bruxism, Physiotherapy, Orafacial Pain","enrollment":30},{"nctId":"NCT06936748","phase":"PHASE2","title":"SFRT+Sequential Hypofractionated/Conventional Fractionated RT+Iparomlimab and Tuvonralimab for Relapsed/Refractory Solid Tumors","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital of Nanchang University","startDate":"2025-06-20","conditions":"Cancer","enrollment":30},{"nctId":"NCT04179162","phase":"PHASE1, PHASE2","title":"Bacillus Calmette-Guérin (BCG) and Gemcitabine in People With High-Grade Non-Muscle Invasive Bladder Cancer That Came Back After BCG Treatment","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2019-11-22","conditions":"Non-Muscle Invasive Bladder Cancer (NMIBC)","enrollment":54},{"nctId":"NCT04952480","phase":"PHASE2","title":"Dose-escalated Adaptive Radiotherapy of Thoracic Disease for Small Cell Lung Cancer","status":"RECRUITING","sponsor":"AHS Cancer Control Alberta","startDate":"2022-06-13","conditions":"Small Cell Lung Cancer","enrollment":31},{"nctId":"NCT05470777","phase":"PHASE2","title":"CD22/CD19 CAR-T and Auto-HSCT Sandwich Strategy as Consolidation Therapy for B-ALL","status":"RECRUITING","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2020-01-19","conditions":"B-cell Acute Lymphoblastic Leukemia","enrollment":37},{"nctId":"NCT06992479","phase":"NA","title":"Efficacy of HFNC Combined With Sequential NIV in Patients With COPD Complicated With Type II Respiratory Failure","status":"COMPLETED","sponsor":"Beijing YouAn Hospital","startDate":"2021-01-01","conditions":"Chronic Obstructive Pulmonary Disease (COPD), Nasal High Flow Oxygen Therapy, Noninvasive Ventilation","enrollment":100},{"nctId":"NCT04502758","phase":"NA","title":"Sequential Bilateral Accelerated Theta Burst Stimulation in Adolescents With Suicidal Ideation","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2022-04-04","conditions":"Suicidal Ideation, Major Depressive Disorder","enrollment":80},{"nctId":"NCT06929962","phase":"PHASE4","title":"VA Dual Sequential Therapy","status":"RECRUITING","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2025-04-24","conditions":"Helicobacter Pylori Infection","enrollment":600},{"nctId":"NCT04142177","phase":"NA","title":"Sequential and Comparative Evaluation of Pain Treatment Effectiveness Response","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2022-06-13","conditions":"Chronic Low Back Pain","enrollment":2529},{"nctId":"NCT05363293","phase":"PHASE1, PHASE2","title":"Multiple Ascending Dose Safety, Tolerability, PK Study of AL001 in Alzheimer's Disease Patients & Healthy Adult Subjects","status":"COMPLETED","sponsor":"Alzamend Neuro, Inc.","startDate":"2022-05-04","conditions":"Alzheimer's Disease, Healthy Non-elderly and Elderly Adults","enrollment":65},{"nctId":"NCT05716009","phase":"PHASE1","title":"Tagraxofusp-erzs, an IL-3 Diphtheria Fusion Protein, in Combination With Gemtuzumab Ozogamicin in Patients With Relapsed/Refractory AML","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2023-11-20","conditions":"Acute Myeloid Leukemia","enrollment":36},{"nctId":"NCT04760275","phase":"PHASE3","title":"Fluoxetine vs CBT in Childhood Anxiety Disorders","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Hospital Los Angeles","startDate":"2021-02-10","conditions":"Anxiety Disorders","enrollment":316},{"nctId":"NCT05804669","phase":"PHASE1, PHASE2","title":"A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome","status":"RECRUITING","sponsor":"Crinetics Pharmaceuticals Inc.","startDate":"2023-10-12","conditions":"Cushing Syndrome, Cushing Disease, Ectopic ACTH Syndrome","enrollment":18},{"nctId":"NCT06246344","phase":"","title":"Adaptive Boost Radiotherapy to Primary Lesions and Positive Nodes in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer","status":"RECRUITING","sponsor":"Shandong Cancer Hospital and Institute","startDate":"2023-12-01","conditions":"Rectal Cancer","enrollment":128},{"nctId":"NCT04165330","phase":"PHASE1, PHASE2","title":"Evaluation of AL3818 in Combination With Nivolumab in Solid Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sarcoma Oncology Research Center, LLC","startDate":"2019-10-17","conditions":"Solid Tumor, Adult, Soft Tissue Sarcoma, Non Small Cell Lung Cancer","enrollment":56},{"nctId":"NCT02793687","phase":"PHASE3","title":"Study of Efficacy and Safety of MEXIDOL® in Ischemic Stroke Therapy","status":"COMPLETED","sponsor":"Pharmasoft","startDate":"2015-03-06","conditions":"Ischemic Stroke","enrollment":150},{"nctId":"NCT04942626","phase":"PHASE1","title":"Capecitabine-based Chemoradiotherapy in Combination With the IL-1 Receptor Antagonist Anakinra for Rectal Cancer Patients","status":"COMPLETED","sponsor":"Goethe University","startDate":"2021-08-20","conditions":"Rectal Cancer","enrollment":12},{"nctId":"NCT06317064","phase":"PHASE3","title":"Diagnostic and Therapeutic Potential of Substance P/ NK1R Receptor in Primary Dysmenorrhea","status":"COMPLETED","sponsor":"Lahore Medical Research Center, LLP","startDate":"2024-03-15","conditions":"Primary Dysmenorrhea","enrollment":40},{"nctId":"NCT04722848","phase":"PHASE3","title":"Sequential Treatment With Ponatinib and Blinatumomab vs Chemotherapy and Imatinib in Newly Diagnosed Adult Ph+ ALL","status":"ACTIVE_NOT_RECRUITING","sponsor":"Gruppo Italiano Malattie EMatologiche dell'Adulto","startDate":"2021-09-08","conditions":"Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), ALL, Adult, Philadelphia-Positive ALL","enrollment":236},{"nctId":"NCT04719988","phase":"PHASE2","title":"Anti-PD-1 and mDCF Followed by Chemoradiotherapy in Patients With Stage III Squamous Cell Anal Carcinoma.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre Hospitalier Universitaire de Besancon","startDate":"2022-01-04","conditions":"Squamous Cell Carcinoma of the Anus Stage III","enrollment":55},{"nctId":"NCT06276868","phase":"PHASE2","title":"Darsilide Combined With AI, Trastuzumab and Patuzumab in the Neoadjuvant Treatment of HR+/HER2+ Breast Cancer","status":"RECRUITING","sponsor":"Henan Cancer Hospital","startDate":"2024-01-20","conditions":"Breast Cancer, HER2-positive Breast Cancer","enrollment":71},{"nctId":"NCT06420076","phase":"PHASE1, PHASE2","title":"Sequential CAR-T Cells Therapy for CD5/CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD5/CD7-Specific CAR-T Cells","status":"RECRUITING","sponsor":"Essen Biotech","startDate":"2024-07-10","conditions":"T Cell Lymphoma, T Cell Leukemia, T-cell Acute Lymphoblastic Leukemia","enrollment":60},{"nctId":"NCT05156203","phase":"PHASE1","title":"Safety and Tolerability Study for T-1301 Capsules to Treat Advanced Solid Tumors","status":"RECRUITING","sponsor":"Taivex Therapeutics Corporation","startDate":"2021-12-19","conditions":"Advanced Solid Tumor, Lymphoma","enrollment":30},{"nctId":"NCT06420063","phase":"PHASE1, PHASE2","title":"Sequential CAR-T Cells Targeting CD33/CD123 in Patients With Acute Myelocytic Leukemia AML","status":"RECRUITING","sponsor":"Essen Biotech","startDate":"2024-07-10","conditions":"AML, Acute Myeloid Leukemia, AML, Adult Recurrent","enrollment":85},{"nctId":"NCT05475431","phase":"","title":"Real-world Treatment of H. Pylori Eradication in Patients with Comorbidity","status":"COMPLETED","sponsor":"National Cheng-Kung University Hospital","startDate":"2020-05-06","conditions":"Helicobacter Pylori Infection, Comorbidities and Coexisting Conditions, Real-world Outcome","enrollment":1053},{"nctId":"NCT05141474","phase":"EARLY_PHASE1","title":"Assessment of the Safety and Tolerability of ex Vivo Next-generation Neoantigen-selected Tumor-infiltrating Lymphocyte (TIL) Therapy in Advanced Epithelial Tumors and Immune Checkpoint Blockade (ICB) Resistant Solid Tumors","status":"RECRUITING","sponsor":"Vall d'Hebron Institute of Oncology","startDate":"2021-10-28","conditions":"Epithelial Tumors, Malignant, Malignant Solid Tumor","enrollment":10},{"nctId":"NCT06428188","phase":"PHASE1, PHASE2","title":"Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune Diseases","status":"RECRUITING","sponsor":"Essen Biotech","startDate":"2024-05-29","conditions":"Autoimmune Diseases, Systemic Lupus Erythematosus, Systemic Lupus Erythematosus Acute","enrollment":60},{"nctId":"NCT05421494","phase":"NA","title":"The Effectiveness of Written Exposure Therapy for PTSD","status":"RECRUITING","sponsor":"Peking University","startDate":"2022-06-15","conditions":"PTSD, Subclinical PTSD","enrollment":135},{"nctId":"NCT01811992","phase":"PHASE1","title":"Combined Cytotoxic and Immune-Stimulatory Therapy for Glioma","status":"COMPLETED","sponsor":"University of Michigan Rogel Cancer Center","startDate":"2014-04","conditions":"Malignant Glioma, Glioblastoma Multiforme","enrollment":19},{"nctId":"NCT06336564","phase":"NA","title":"Microablative Radiofrequency in the Treatment of Urinary Symptoms Associated With Genitourinary Syndrome of Menopause","status":"NOT_YET_RECRUITING","sponsor":"Centro de Atenção ao Assoalho Pélvico","startDate":"2025-08","conditions":"Menopause, Urinary Incontinence","enrollment":40},{"nctId":"NCT05051696","phase":"PHASE2","title":"Intra-tumor Injection of Oncolytic Viruses H101 Combined With or Without Radiotherapy in Refractory/Recurrent Gynecological Malignancies","status":"ACTIVE_NOT_RECRUITING","sponsor":"Liu Zi","startDate":"2021-09-26","conditions":"Genital Neoplasms, Female","enrollment":120},{"nctId":"NCT02025881","phase":"PHASE1, PHASE2","title":"Study of Sequential High-dose Chemotherapy in Children With High Risk Medulloblastoma","status":"TERMINATED","sponsor":"Gustave Roussy, Cancer Campus, Grand Paris","startDate":"2013-09-14","conditions":"High-risk Medulloblastoma","enrollment":29},{"nctId":"NCT06417489","phase":"PHASE4","title":"Evaluation of Efficacy and Safety of Combination Therapy of Henagliflozin Proline, Retagliptin and Metformin in New Diagnosed Type 2 Diabetes Patients","status":"NOT_YET_RECRUITING","sponsor":"Peking University First Hospital","startDate":"2024-05-31","conditions":"Type 2 Diabetes","enrollment":160},{"nctId":"NCT05807932","phase":"PHASE1, PHASE2","title":"Venetoclax in Addition to Sequential Conditioning With Fludarabine / Amsacrine / Ara-C (FLAMSA) + Treosulfan for Allogeneic Blood Stem Cell Transplantation in Patients With MDS, CMML or sAML","status":"RECRUITING","sponsor":"Heinrich-Heine University, Duesseldorf","startDate":"2023-06-26","conditions":"Myelodysplastic Syndromes, Secondary Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia","enrollment":38}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Sequential therapy 10 days","genericName":"Sequential therapy 10 days","companyName":"Incheon St.Mary's Hospital","companyId":"incheon-st-mary-s-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Sequential therapy is a treatment approach that involves a combination of antibiotics to treat bacterial infections. Used for Community-acquired pneumonia, Acute bacterial exacerbation of chronic bronchitis.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}